Literature DB >> 11159960

Lack of adherence of clinical isolates of Pseudomonas aeruginosa to asialo-GM(1) on epithelial cells.

T H Schroeder1, T Zaidi, G B Pier.   

Abstract

Numerous studies have reported that asialo-GM(1), gangliotetraosylceramide, or moieties serve as epithelial cell receptors for Pseudomonas aeruginosa. Usually this interaction is confirmed with antibodies to asialo-GM(1). However, few, if any, of these reports have evaluated the binding of fresh clinical isolates of P. aeruginosa to asialo-GM(1) or the specificity of the antibodies for the asialo-GM(1) antigen. We confirmed that asialo-GM(1) dissolved in dimethyl sulfoxide could be added to the apical membrane of Madin-Darby canine kidney cells growing as a polarized epithelium on Transwell membranes (J. C. Comolli, L. L. Waite, K. E. Mostov, and J. N. Engel, Infect. Immun. 67:3207-3214, 1999) and that such treatment enhanced the binding of P. aeruginosa strain PA103. However, no other P. aeruginosa strain, including eight different clinical isolates, exhibited enhanced binding to asialo-GM(1)-treated cells. Studies with commercially available antibodies to asialo-GM(1) showed that these preparations had high titers of antibody to P. aeruginosa antigens, including whole cells, purified lipopolysaccharide (LPS), and pili. Inhibition studies showed that adsorption of an antiserum to asialo-GM(1) with P. aeruginosa cells could remove the reactivity of antibodies to asialo-GM(1), and adsorption of this serum with asialo-GM(1) removed antibody binding to P. aeruginosa LPS. Antibodies in sera raised to asialo-GM(1) were observed to bind to P. aeruginosa cells by immunoelectron microscopy. Antibodies to asialo-GM(1) inhibited formation of a biofilm by P. aeruginosa in the absence of mammalian cells, indicating a direct inhibition of bacterial cell-cell interactions. These findings demonstrate that asialo-GM(1) is not a major cellular receptor for clinical isolates of P. aeruginosa and that commercially available antibodies raised to this antigen contain high titers of antibody to multiple P. aeruginosa antigens, which do not interfere with the binding of P. aeruginosa to mammalian cells but possibly interfere with the binding of P. aeruginosa cells to each other.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159960      PMCID: PMC97944          DOI: 10.1128/IAI.69.2.719-729.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  A method for the determination of antibody affinity using a direct ELISA.

Authors:  A Schots; B J Van der Leede; E De Jongh; E Egberts
Journal:  J Immunol Methods       Date:  1988-05-09       Impact factor: 2.303

2.  Analysis of adhesion, piliation, protease production and ocular infectivity of several P. aeruginosa strains.

Authors:  L D Hazlett; M M Moon; A Singh; R S Berk; X L Rudner
Journal:  Curr Eye Res       Date:  1991-04       Impact factor: 2.424

3.  Comparison of adherence of Pseudomonas aeruginosa to respiratory epithelial cells from cystic fibrosis patients and healthy subjects.

Authors:  L Saiman; G Cacalano; D Gruenert; A Prince
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

4.  Crystal structure of Pseudomonas aeruginosa PAK pilin suggests a main-chain-dominated mode of receptor binding.

Authors:  B Hazes; P A Sastry; K Hayakawa; R J Read; R T Irvin
Journal:  J Mol Biol       Date:  2000-06-16       Impact factor: 5.469

5.  Production of the Pseudomonas aeruginosa neuraminidase is increased under hyperosmolar conditions and is regulated by genes involved in alginate expression.

Authors:  G Cacalano; M Kays; L Saiman; A Prince
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

6.  Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development.

Authors:  G A O'Toole; R Kolter
Journal:  Mol Microbiol       Date:  1998-10       Impact factor: 3.501

7.  Characterization of pseudomonal adherence to unwounded cornea.

Authors:  A Singh; L Hazlett; R S Berk
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-06       Impact factor: 4.799

8.  Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipids.

Authors:  H C Krivan; D D Roberts; V Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

9.  Nucleotide sequence and transcriptional initiation site of two Pseudomonas aeruginosa pilin genes.

Authors:  K Johnson; M L Parker; S Lory
Journal:  J Biol Chem       Date:  1986-11-25       Impact factor: 5.157

10.  The effect of piliation and exoproduct expression on the adherence of Pseudomonas aeruginosa to respiratory epithelial monolayers.

Authors:  L Saiman; K Ishimoto; S Lory; A Prince
Journal:  J Infect Dis       Date:  1990-03       Impact factor: 5.226

View more
  17 in total

Review 1.  Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function.

Authors:  David G Thanassi; James B Bliska; Peter J Christie
Journal:  FEMS Microbiol Rev       Date:  2012-05-24       Impact factor: 16.408

2.  Molecular basis for defective glycosylation and Pseudomonas pathogenesis in cystic fibrosis lung.

Authors:  J F Poschet; J C Boucher; L Tatterson; J Skidmore; R W Van Dyke; V Deretic
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

3.  Interleukin-8 production by human airway epithelial cells in response to Pseudomonas aeruginosa clinical isolates expressing type a or type b flagellins.

Authors:  Kathleen K Shanks; Wei Guang; K Chul Kim; Erik P Lillehoj
Journal:  Clin Vaccine Immunol       Date:  2010-06-30

4.  Cryoelectron Microscopy Reconstructions of the Pseudomonas aeruginosa and Neisseria gonorrhoeae Type IV Pili at Sub-nanometer Resolution.

Authors:  Fengbin Wang; Mathieu Coureuil; Tomasz Osinski; Albina Orlova; Tuba Altindal; Gaël Gesbert; Xavier Nassif; Edward H Egelman; Lisa Craig
Journal:  Structure       Date:  2017-09-05       Impact factor: 5.006

5.  Pseudomonas aeruginosa mucoid strain 8830 binds glycans containing the sialyl-Lewis x epitope.

Authors:  Baoyun Xia; Goverdhan P Sachdev; Richard D Cummings
Journal:  Glycoconj J       Date:  2007-01       Impact factor: 2.916

6.  N-glycosylation augmentation of the cystic fibrosis epithelium improves Pseudomonas aeruginosa clearance.

Authors:  Ashley T Martino; Christian Mueller; Sofia Braag; Pedro E Cruz; Martha Campbell-Thompson; Shouguang Jin; Terence R Flotte
Journal:  Am J Respir Cell Mol Biol       Date:  2010-08-06       Impact factor: 6.914

7.  Cross-sectional analysis of clinical and environmental isolates of Pseudomonas aeruginosa: biofilm formation, virulence, and genome diversity.

Authors:  Nathan E Head; Hongwei Yu
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Pseudomonas aeruginosa-mediated damage requires distinct receptors at the apical and basolateral surfaces of the polarized epithelium.

Authors:  Iwona Bucior; Keith Mostov; Joanne N Engel
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

Review 9.  Mimicking the host and its microenvironment in vitro for studying mucosal infections by Pseudomonas aeruginosa.

Authors:  Aurélie Crabbé; Maria A Ledesma; Cheryl A Nickerson
Journal:  Pathog Dis       Date:  2014-05-23       Impact factor: 3.166

10.  Disruption of CFTR-dependent lipid rafts reduces bacterial levels and corneal disease in a murine model of Pseudomonas aeruginosa keratitis.

Authors:  Tanweer Zaidi; Milan Bajmoczi; Tauqeer Zaidi; David E Golan; Gerald B Pier
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.